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Objective: Our objective was to analyze the potential advantage of combin- 
ing an intraaortic balloon pump with a transthoracic Hemopum p device 
(Medtronic, Inc., Minneapolis, Minn.) (Nimbus Medical, Inc., Rancho 
Cordova, Calif.). Methods: Twelve sheep underwent implantation of a 
transthoracic Hemopump device and an intraaortic balloon pump, In the 
first series (n = 6), we analyzed the influence of the counterpulsation the 
performance of the Hemopump device. In the second group (n = 6), 
hemodynamic changes, myocardial wall thickening, organ perfusion, and 
myocardial perfusion (determined with colored microspheres) were ana, 
lyzed under the following conditions: (1) control situation, (2) during 
application of coronary stenosis, (3) during support with the Hemopump 
device, and (4) during support with the Hemopump device combined with 
intraaortie balloon pump support. Results: In the first series, we found that 
addition of counterpulsation reduced output with the Hemopump device by 
11.1% - 6%. In the second series, it was shown that coronary stenosis 
significantly reduced contractility (rate of pressure change and wall 
thickening) but did not cause hemodynamic collapse. Myocardial blood 
flow was significantly reduced in the poststenotic subendoeardial regions 
(mean subendocardial b ood flow dropped from 78 - 33 to 24 --_ 17 
m!/min/100 gm; p = 0.0486). Support with the Hemopump device alone 
improved the ratio of subendocardial to subepicardial blood flow, but 
endocardial underperfusion remained (analysi s of variance, p < 0.001). 
The Hemopump device with an intraaortic balloon pump completely 
restored perfusion in poststenotic regions. Peripheral organ perfusion did 
not change during ischemia or mechanical support, Conclusions: The 
association of balloon counterpulsation with the Hemopump device reduces 
the Hemopump output by 11% and increases myocardial blood flow to 
ischemic regions. Perfusion to peripheral organs remains unaltered. The 
transthoracic Hemopump device combined with an intraaortic balloon 
pump is an ideal support system for the ischemic, failing heart. (J Thorac 
Cardiovasc Surg 1997;114:243-53) 
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I ntraaortic balloon pumping is an established 
method of supporting the failing heart, Intraaortic 
balloon pump'( IABP)  devices have been continu- 
ously improved since Moulopoulos, Topaz, and 
Kolff I introduced coun terpulsation by means of an 
intraaortic balloon in 1962. Experimental work has 
shown that balloon counterpulsation reduces left 
ventricular work and increases myocardial perfu- 
sion. 2-4 The concept of the Hemopump device 
(Medtronic, Inc., Minneapolis, Minn.) is completely 
different. This device is a miniature rotary blood 
pump introduced into the left ventricular cavity 
through the aortic valve. It aspirates the blood from 
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Fig. 1. Experimental protocol setup./, Hemopump flow 
is diverted through Y-graft and measured by electromag- 
netic flowmeter; 2, intraaortic balloon is inserted through 
femoral artery. 
the left ventricular cavity and expels it in the ascend- 
ing aorta. The most frequently used and most reli- 
able cannula is the transthoracic cannula, which is 
introduced through a graft sutured on the ascending 
aorta. This transthoracic Hemopump device is a 
powerful pump, with a rotational speed of 26,000 
rpm producing a maximum pump flow of 5.1 L/min. 
The performance of this nonpulsatile blood pump, 
however, is dependent on the actual pressure differ- 
ences between inflow and outflow of this pump. 
With a mean aortic pressure of 70 mm Hg in the 
clinical situation, the pump thus produces approxi- 
mately 4 L/rain. The Hemopump device increases 
myocardial blood flow by decreasing ventricular 
end-diastolic pressure and by increasing mean aortic 
blood pressure. 5 Most clinicians prefer the less 
invasive IABP as the first choice for mechanical 
support in cases of low cardiac output because the 
use of the transthoracic Hemopump device requires 
a sternotomy for both insertion and removal. The 
transthoracic Hemopump device is considered a 
"second-line" mechanical support device for pa- 
tients who do not recover despite the use of an 
IABP. An IABP is thus often already in place when 
the Hemopump device is introduced. The transtho- 
racic Hemopump device and the IABP inserted 
through the groin can easily be combined, so we 
studied whether the combination of these devices 
could be beneficial. 
Materials and methods 
Animal instrumentation. Twelve sheep (mean weight 
69.8 _+ 15 kg) were anesthetized with intravenous pento- 
barbital (3 mg/kg), intubated, and mechanically ventilated 
with 60% oxygen. Anesthesia was maintained with 0.5% 
to 2% halothane, and 0.2 mg/kg piritramide was adminis- 
tered every 40 minutes. All animals received humane care 
in compliance with the "Guide for the Care of and Use of 
Laboratory Animals" prepared by the Institute of Labo- 
ratory Animal Resources and published by the National 
Institutes of Health NIH Publication No. 86-23, revised 
1985. 
A triple-lumen central venous line was inserted into the 
jugular vein, and a fluid-filled pressure catheter was 
placed in the carotid artery. Both were placed through a 
cutdown in the left side of the neck. Left thoracotomy was 
performed through the fifth intercostal space. Heparin 
was administered at300 U/kg. When the pericardium was 
opened, 100 mg lidocaine (Xylocaine) was administered. 
The left groin was incised and a 40 ml intraaortic balloon 
(Datascope Inc., Paramus, N.J.) was introduced through 
the femoral artery. The balloon was positioned in the 
descending thoracic aorta. A fluid-filled pressure line was 
inserted in the left atrium and a Mikro-Tip catheter 
transducer (Millar Instruments, Inc., Houston, Tex.) was 
placed in the left ventricle through the apex. All pressure 
transducers were connected to a Triton pressure module 
(Triton, San Diego, Calif.). Two different instrumentation 
procedures were performed: one group of six animals was 
implanted with instruments for accurate measurements of 
flow through the Hemopump device (protocol 1); the 
other group of six animal s was implanted with instruments 
for hemodynamic and organ perfusion analysis (protocol 
2). 
Protocol 1. In the first group of six animals, the ascend- 
ing aorta was encircled and a 12 mm Dacron polyester 
fabric Y-graft was sutured to the aorta. A second graft of 
the same size was sutured to the descending aorta, and the 
grafts were interconnected with an inflow electromagnetic 
flowmeter of 3/8 inch (Cliniflow II, model FM 701 D; 
Carolina Medical Electronics, Inc., N.C.; Fig. 1). A trans- 
thoracic Hemopump cannula was transvalvularly placed in 
the left ventricle through the side arm of the Y-graft. The 
side arm was occluded by the occluders provided with the 
Hemopump device, diverting the produced Hemopump 
flow through the flowmeter back to the descending aorta 
(Fig. 1). The metal outflow part of the Hemopump device 
was positioned in the graft, and a suture around the graft 
secured the pump in this position and prevented leakage 
of flow along the Hemopump device into the ascending 
aorta. 
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Fig. 2. Experimental protocol. Colored microspheres are injected at five different times. Modes of 
mechanical support (Hemopump device alone and Hemopump device with IABP) alternated between 
experiments. 
Protocol 2. In the second group of six animals, a 12 mm 
Dacron polyester fabric graft was sutured to the ascending 
aorta for introduction of the transthoracic Hemopump 
cannula. The lateral branch of the left coronary artery was 
visualized in the atrioventricular groove near its origin. An 
electromagnetic flow probe was positioned around it and 
connected to a Nyhon Kohden (Tokyo, Japan) flowmeter. 
A second electromagnetic flowmeter (model 1401; Skalar, 
Delft, The Netherlands) was placed around the pulmo- 
nary artery for continuous measurement of cardiac out- 
put. A set of ultrasonic transit-time crystals consisting of 
one endocardial crystal and one epicardial crystal was 
sutured to the posterolateral region of the heart. These 
crystals were connected to a sonomicrometer module 
(Triton, San Diego, Calif.) for measurement of wall 
thickening. 
Experimental protocols. In the first protocol (n = 6), 
we wanted to analyze the effect of the IABP on the flow 
production by the Hemopump device. The flow through 
the graft (Hemopump flow) was measured for the seven 
different rotational speeds provided by the Hemopump 
console. Flow and pressure measurements were analyzed 
from beat to beat and flows were expressed in relation to 
pressure. Aortic pressure, left ventricular pressure, first 
derivative of the left ventricular pressure, electrocardio- 
graph tracing, aortic flow, and Hemopump flow were 
recorded on a Nyhon Kohden chart recorder. Aortic flow, 
left ventricular pressure, first derivative of the left ventric- 
ular pressure, Hemopump flow and aortic flow were 
on-line registered on computer by means of Labview 
software (National Instruments, Austin, Texas). These 
curves were analyzed and stored in their numeric form. 
Measurements were repeated with the balloon pump 
working in an electrocardiographically triggered 1-to-1 
mode. At the end of the experiment, the heart was opened 
to confirm the intraventricular position of the He- 
mopump. 
In the second protocol (n = 6), we focused on hemo- 
dynamic hanges, organ perfusion, and myocardial perfu- 
sion during Hemopump support alone and with IABP 
support. Myocardial wall thickening, left ventricular pres- 
sure, first derivative of the left ventricular pressure, arte- 
rial blood pressure, coronary flow, cardiac output, and left 
atrial pressure were continuously recorded on an eight- 
channel chart recorder (Nyhon Kohden). After stabiliza- 
tion, a first set of colored microspheres was injected into 
the left atrium (Fig. 2). 
A stenosis was applied to the lateral branch of the left 
coronary artery. This stenosis was tightened until a drop 
of 50% in the baseline coronary flow in that vessel 
occurred and was then left untouched for 10 minutes. 
After 5 minutes of stenosis, a second set of colored 
microspheres was injected through the left atrial catheter 
and the mechanical support was started (Fig. 2). Five 
minutes later, a third injection of microspheres was given. 
The stenosis was relieved and time was allowed for all 
parameters to stabilize. Then the same stenosis was 
applied again and a fourth set of microspheres was 
injected after 5 minutes. This time the second condition of 
mechanical support was started, and 5 minutes later the 
fifth set of microspheres was given. The modes of mechan- 
ical support (Hemopump device alone and Hemopump 
device with IABP) were alternated in sequence of use. 
Myocardial and organ flow measurement with colored 
microspheres. Nine million 15 mm diameter polystyrene 
microspheres of five different colors (white, red, yellow, 
blue, and violet) were injected on five different occasions 
during the experiment. The microspheres were injected in 
a volume of 3 ml over 30 seconds. Arterial reference blood 
was withdrawn during 90 seconds from the aorta at a flow 
rate of 10 ml/min. On termination of the experiment, 1 gm 
tissue samples were isolated from lungs, cerebrum, cere- 
bellum, spleen, liver, pancreas, stomach, small bowel, 
large bowel, renal cortex, renal medulla, skin, and mus- 
cles. 
The hearts were removed, trimmed of excess fat, and 
cut in five slices along the short axis. Each slice was then 
cut and unrolled into a myocardial strip (Fig. 3). Three 
right ventricular and nine left ventricular egions were 
identified and biopsy samples were taken from each zone 
from the subepicardium as well as from the subendocar- 
dium. The second slice (counting from the base of the 
heart) from each animal was processed for quantification 
of the colored microsphere content. The colored micro- 
sphere content was determined by the methods described 
by Kowallik and 6 coworkers, Rudolph and Heymann, 7 and 
Wieland and colleagues. 8 
Data analysis. Computer sampling of the signals was 
performed at a rate of 1000 samples per second. Logging 
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Fig. 3. The heart is cut into five slices. Each slice is unrolled into a myocardial strip. Colored microsphere 
content is analyzed in subendocardial and subepicardial biopsy samples from three right ventricular ( v) 
and nine left ventricular (lv) regions. Regions lv4, lvS, and lv6 are ischemic regions when the lateral branch 
of the left coronary artery is stenosed. 
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Fig. 4. Mean Hemopump flow (-+ standard error) with- 
out (closed circles) and with (open circles) IABP for 
different rotational speeds. Difference is significant when 
pump is turned off and at speed 1. 
of the data covered 1 second of data per log. Thus, 
depending on the animal's heart rate, one or two heart- 
beats were analyzed at a time. Data were analyzed with 
the Statistica statistical software package (Statsoft Inc., 
Tulsa, Okla.). Organ flows and hemodynamic data are 
presented as means plus or minus the standard eviation. 
Myocardial blood flow values in different zones of the 
heart were analyzed with analysis of variance (ANOVA) 
for repeated measurements. Hemodynamic data were 
analyzed with ANOVA for repeated measurements and 
with a one-way multivariate ANOVA for differences 
between modes of mechanical support. Paired compari- 
sons with control values were performed with the two- 
tailed paired Student's t test. 
Results 
Influence of the IABP on the performance of the 
Hemopump device. The IABP reduced the perfor- 
mance of the Hemopump device. Fig. 4 shows the 
mean flow produced at the different rotational 
speeds by the Hemopump device and by the combi- 
nation of the Hemopump device with the IABP. In 
the control situation, with the Hemopump device 
switched off, a backflow was measured through the 
cannula (-0.39 L/rain). This backflow was further 
increased to -0.49 L/rain by the IABP (increase of 
the baekflow by 20%). When the Hemopump device 
was working, the IABP reduced the flow by 11.1% at 
all rotational speeds. This reduction of the He- 
mopump flow by the IABP was only significant in 
the control situation and at low speed. 
The Journal of Thoracic and 
Cardiovascular Surgery 
Volume 114, Number 2 
Meyns et aL 247 
10C 
10C 
5 
0 
Fig. 5. Left ventricular pressure, aortic blood pressure, Hemopump flow and electrocardiographic (ECG) 
tracing during Hemopump run with 1 in 2 counterpulsation assist. Diastolic pressure (arrow) augmented 
by the intraaortic balloon causes a drop in Hemopump flow (arrow). Systolic peak flows remain unchanged. 
The increased iastolic blood pressure increased 
the pressure head of the Hemopump device and 
reduced iastolic pump flow. This is shown in Fig. 5. 
With the IABP in a 1-in-2 frequency, one can clearly 
identify the reduced iastolic flow production in the 
IABP-assisted beat versus the unassisted beat. 
Hemodynamic hanges, unloading, and contrac- 
tility. Systolic arterial blood pressure, diastolic ar- 
terial blood pressure, cardiac output, and left atrial 
pressure are shown in Fig. 6. The influence of the 
coronary stenosis on overall hemodynamics was 
mild. There was no significant drop in total cardiac 
output or perfusion pressure. The use of the He- 
mopump device significantly increased the diastolic 
blood pressure (from 55 _+ 15 to 75 + 22 mm Hg; 
p = 0.0088), but the combination of Hemopump 
device and IABP was even more effective in increas- 
ing the diastolic blood pressure (from 56 _+ 11 to 
88 _+ 6 mm Hg; p < 0.00001). Left atrial pressures 
were increased uring ischemia nd reduced as soon 
as the mechanical support commenced. There was 
no difference in the reduction of the left atrial 
pressure between modes of mechanical support. 
The maximum and minimum values of the first 
derivative of the left ventricular pressure changed 
significantly during the experiment (Fig. 7). There was 
a severe drop in contractility when the stenosis was 
applied, and the heart was further unloaded when the 
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Fig. 6. Hemodynamic changes during ischemia nd mechanical support. A, Systolic blood pressure; B, 
diastolic blood pressure; C, left atrial pressure; and D, cardiac output for Hemopump device alone (closed 
circles) and Hemopump device with IABP (open circles). Only diastolic blood pressure during assistance 
with both Hemopump device and IABP shows significant change (asterisk). 
Hemopump device was started. The association of the 
IABP did not influence this pattern. The wall-thicken- 
ing fraction (Fig. 8) was significantly reduced during 
ischemia. This measurement of contractility was not 
altered by assisting the heart with the intraventricular 
Hemopump device nor with the Hemopump device 
and IABP. 
Peripheral organ perfusion. Peripheral organ 
perfusions are shown in Table I. The perfusion was 
measured by colored microspheres before the appli- 
cation of the stenosis, 5 minutes after the applica- 
tion of the stenosis, and during mechanical support 
(with the stenosis still applied). Major changes in 
pulmonary and splenic perfusion were noted during 
the different conditions. We consider lung perfusion 
to be an unreliable measurement in an open-chest 
experiment, however, because pulmonary manip- 
ulations are frequent. Similarly, the ovine spleen 
act as a blood pooling organ and adjusts for rapid 
fluid changes. We therefore also do not consider 
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Hemopump device alone (closed circles) and Hemopump 
device with IABP (open circles). Significant difference 
from control value is indicated by asterisk. 
Table I. Mean organ blood flow in milliliters per minute per 100 gm of tissue (+_ standard deviation) 
Control Ischemia HP alone Ischemia HP + IABP 
Lung 117 _+ 21 146 _+ 81 158 +_ 82 127 +_ 66 248 ± 123 
Cerebrum 72 ± 28 55 ± 28 72 _+ 43 84 ± 66 80 ± 28 
Cerebellum 51 ± 27 45 + 24 54 _+ 10 59 -+ 39 63 _+ 24 
Spleen 75 _+ 60 20 ± 10 36 ± 11 20 +- 14 27 _+ 16 
Liver 28+_5 19_+10 20±9 16±3 19±9 
Renal cortex 202 + 40 175 _+ 60 177 ± 97 180 ± 70 178 ± 90 
Renal medulla 27 ± 13 26 + 16 23 -+ 8 21 -+ 9 19 ± 9 
Stomach 20 +_ 10 22 _+ 18 31 ± 17 16 ± 9 14 ± 8 
Small bowel 42 _+ 15 36 -+ 25 36 ± 8 31 +_ 10 35 ± 16 
Pancreas 43 ± 15 37 +- 15 60 -+ 46 41 ± 22 44 ± 18 
Large bowel 22 _+ 12 23 ± 17 25 + 20 22 ± 13 15 _+ 10 
Muscle 7+-6 5±4 5±4 4±3 2±1 
Skin 9+_7 7±6 11±9 5+4 5_+3 
No significant differences for the different conditions. HP, Hemopump. 
the splenic perfusion data to be clinically useful. 
There were no statistically significant changes in 
organ perfusion between the control values and 
the ischemic values (hemodynamics did not 
change). Also, the mechanical support did not 
alter peripheral organ perfusion. There was no 
difference in peripheral organ perfusion between 
the Hemopump device alone and the combination 
of Hemopump device with IABP. 
Myocardial perfusion. Myocardial perfusion 
was measured by the colored microsphere tech- 
nique in different regions of the heart, both in the 
subendocardium and in the subepicardium. We 
thus obtained the subendocardial b ood flow, the 
subepicardial blood flow, and the ratio of subendocar- 
dial to subepicardial b ood flow. Figs. 9 through 11 
show the means of the different animals in the same 
myocardial regions for three different conditions: (1) 
control value before the stenosis was applied, (2) the 
ischemic value measured 5 minutes after applica- 
tion of the stenosis, and (3) the assisted value 
measured 5 minutes after the start of mechanical 
support (with the stenosis still in place). These 
curves are presented for subendocardial blood 
flow (Fig. 9), subepicardial blood flow (Fig. 10), 
and the ratio of subendocardial to subepicardial 
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Fig. 9. Subendocardial blood flow in 12 different regions of 
myocardial s ice (see Fig. 3). Regions from right ventricle are 
rva, rvl, and rvp; lvl through/v9 are from left ventricle. Each 
panel shows myocardia! perfusion i  control situation (closed 
diamonds), during ischemia (open circles), and during me- 
chanical suppor t (closed squares). Asterisks indicate signifi- 
cant differences from the control value. A, Hemopump 
device with IABP; B, Hemopump device alone. 
flow (Fig. 11) for assistance with the Hemopump 
device alone and with the IABP. 
After application of the stenosis on the lateral 
branch of the left coronary artery, the myocardial 
blood flow was statistically significantly changed in the 
subendocardial regions (ANOVA, p < 0.001). This 
drop in blood flow was seen in the posterolateral zones 
of the left ventricle (Fig. 9). The mean subendocardial 
blood flow in these regions dropped from 78 = 33 to 
24 z 17 ml/min/100 gm (p = 0.0486) The changes in 
the epicardial blood flow (Fig. 10) were not statistically 
significant (ANOVA, p = 0.0704; mean from 64 -- 26 
to 57 -+ 40 ml/min/100 gm,p > 0.2). As a consequence, 
the ratio of subendocardial to subepicardial b ood flow 
(Fig. 11) was significantly reduced (ANOVA. p < 
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Fig. 10. Subepicardial b ood flow in 12 different regions of 
myocardial s ice (see Fig. 3). Regions from right ventricle are 
rva, rv~ and rvp; lvl through lv9 are from left ventricle. Each 
panel shows myocardial perfusion in control situation (closed 
diamonds), during ischemia (open circles), and during me- 
chanical support (closed squares). Asterisks indicate signifi- 
cant differences from the control value. A, Hemopump 
device with IABP; B, Hemopump device alone. 
0.001; mean from 1.23 ± 0.11 to 0.48 ± 0.26, p = 
0.0022). 
Assistance with the Hemopump device improved 
myocardial f ow to a small extent (Figs. 9, A, 10, A, 
and 11, A). The mean subendocardial blood flow in 
the ischemic regions rose from 24 _ 17 to 44 ± 40 
ml/min/100 gm (p > 0.2), the subepicardial flow rose 
from 45 ± 31 to 55 ± 45 ml/min/100 gm, and the 
ratio rose from 0.48 ± 0.22 to 0.85 ± 0.59 (p > 0.2). 
For the subendocardial myocardial perfusion, the 
ANOVA still showed a significant difference from 
the control situation (p < 0.001; Fig. 9, A). 
Support with the combination of the He- 
mopump device and IABP improved myocardial 
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blood flow to a greater extent (Figs. 9, B, 10, B, 
and 11, B). Subendocardial b ood flow improved 
from 24 _+ 17 to 63 + 57 ml/min/100 gm (p > 0.2), 
epicardial blood flow remains unchanged from 
57 -+ 40 to 57 + 44 ml/min/100 gm, and the ratio 
increased from 0.48 + 0.28 to 1.26 +- 1.23 (p - 
0.1750). As a consequence, there was no signifi- 
cant difference from the control situation 
(ANOVA for subendocardial flow p > 0.2). 
Discussion 
Clinical practice has led us to the combined use of 
the transthoracic Hemopump device and the IABP. 9 
In cases of postcardiotomy heart failure, the IABP 
remains the first choice as a mechanical support de- 
vice. The device is easily introduced through the 
femoral artery, has an acceptable complication 
rate,10,11 and has been shown to be beneficial by 
increasing myocardial perfusion and reducing left ven- 
tricular work. 2-4 In cases of persistent low cardiac 
output despite pharmacologic support and IABP use, 
we consider the transthoracic Hemopump device to be 
the first choice as a left ventricular assist device. This 
pump is powerful (produces up to 5 L/rain), also is 
easily introduced, and has proved to be technically 
reliable, as opposed to the femoral cannulas of the 
Hemopump device. With the IABP already in place, 
we introduced the transthoracic Hemopump device 
and thus created the combination ofthese devices. We 
suspected a possible beneficial effect on myocardial 
flow and were intrigued by the gradual weaning pos- 
sibilities (first weaning from the Hemopump device 
and then from IABP). 
This experimental study proves our theoretic hy- 
pothesis to be sound. First. the increase in diastolic 
blood pressure created by the IABP reduced the 
Hemopump flow. Second, the higher diastolic per- 
fusion pressure created an increase in myocardial 
blood flow in ischemic regions. With the colored 
microsphere technique, we showed that the He- 
mopump device and IABP combination returned 
subendocardial flow in ischemic regions to normal. 
Hemodynamic effects. We did not intend to cause 
hemodynamic collapse by the applied coronary steno- 
sis. On the contrary, our intention was to show the 
specific effects of the assisted circulation on myocardial 
perfusion. In a model of cardiogenic shock, the simple 
increase of cardiac output and arterial blood pressure 
by the Hemopump device should itself influence the 
myocardial perfusion. We therefore preferred to cre- 
ate a stenosis with 50% flow reduction, rather than a 
complete occlusion. In consequence we did not study 
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Fig. 11. Ratio of subendocardial to subepicardial blood 
flow in 12 different regions of myocardial slice (see Fig. 3). 
Regions from right ventricle are rva, rv!, and rvp; Iv1 
through lv9 are from left ventricle. Each panel shows 
myocardial perfusion in control situation (closed dia- 
monds), during ischemia (open circles), and during me- 
chanical support (closed squares ) .Asterisks indicate signif- 
icant differences from the control value. A, Hemopump 
device with IABP; B, Hemopump device alone. 
the effects of cardiogenic shock. Total cardiac output 
and blood pressure did not significantly change during 
the created "ischemia." The effects of the Hemopump 
device alone and with IABP support were therefore 
minimal; there was no change in total cardiac output. 
Organ perfusion. We could not identify any effect 
on peripheral organ perfusion. In this series of exper- 
iments, the myocardial stenosis was only applied with 
the purpose of creating an ischemic subendocardial 
region. We did not intend to cause myocardial failure 
and subsequent shock. The so-called "ischemic values" 
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of peripheral organ perfusion thus do not differ from 
the control values. However, the fact that assistance 
with the Hemopump device alone and with IABP did 
not alter this organ perfusion is important. It proves 
that the organ perfusion in the assisted situation (with 
the nonpu!satile Hemopump device) is similar to that 
in the normal or unassisted situation. Associating an 
IABP and adding to the pulsatility of the flow did not 
change the organ perfusion. This finding underlines 
our clinical experience, where several of our patients 
with nonpulsatile assistance had good organ function. 9 
Myocardial perfusion. Several series have shown 
that myocardial perfusion is increased by support with 
the Hemopump device. 5'12, 13 These experiments in 
dogs studied myocardial perfusion after occlusion of 
the left anterior descending coronary artery. Such an 
occlusion will always impair the hemodynamic status 
of the animal, and the beneficial effect of the He- 
mopump device on myocardial perfusion is therefore 
due in part to the treatment ofthe cardiac shock. The 
coronary stenosis used in our experiments did not alter 
cardiac output or perfusion pressures. The changes in 
myocardial blood flow in this study were thus due 
purely to the unloading capacities of the Hemopump 
device. We caused asignificant drop in subendocardial 
perfusion during ischemia. The Hemopump device 
improved the ratio of subendocardial to subepicardial 
blood flow, and this effect was caused by the decreased 
end-diastolic left ventricular pressure, 3 as also illus- 
trated by the decrease in left atrial pressure (from 
12.5 _ 4.8 to 8.4 _+ 5 mm Hg). Moreover, the 
Hemopump device strongly unloaded the heart (de- 
crease in first derivative of pressure from 1089 __ 448 
to 505 + 277; p < 0.001) and therefore reduced 
myocardial oxygen need. The Hemopump device in- 
creased the subendocardial blood flow in the ischemic 
areas to a small extent (from 24 __+ 17 to 44 _+ 40 
ml/mirgl00 gm; p > 0.2), and a significant underper- 
fusion compared with the control situation remained 
(ANOVA, p < 0.001). 
Perfusion pressure (and particularly diastolic per- 
fusion pressure) is the most important parameter 
for coronary flow in the ischemic, vasodilated vas- 
cular bed. The association of the IABP with the 
Hemopump device combined both advantages, un- 
loading and high diastolic pressure, to create an 
almost ideal situation. Coronary flow in the ischemic 
subendocardial region was returned completely to 
normal (no statistically significant difference from 
the control situation; ANOVA, p > 0.2) and the 
unloading features of the Hemopump device remain 
unchanged. In other words, myocardial flow was re- 
turned to normal and oxygen eed was reduced; one 
could hardly assist he ischemic heart in a better way. 
To validate our experimental results in the clinical 
situation, the studied animals' weights needed to be 
similar to those of human beings. Otherwise, the effect 
of the mechanical support systems could have been 
overestimated. We therefore chose to use sheep. One 
anatomic difference between human beings and sheep 
must be considered in this experimental setup. The 
ovine descending aorta is relatively small in compari- 
son to the human aorta. This means that the effect on 
the ovine heart of an IABP in the descending aorta 
remains rather moderate in comparison with that in 
the human heart. Taking this into consideration, it is 
possible that he IABP effect on the heart will be more 
pronounced in human beings than we were able to 
demonstrate in these sheep. 
This physiologic insight has shown us that the 
Hemopump device with IABP is an ideal support 
system in cases of ventricular failure from ischemia. 
However, the addition of the IABP is not always 
beneficial. It neither contributes to nor reduces the 
peripheral organ perfusion, and it reduces the flow 
produced by the Hemopump device by approxi- 
mately 10%. In all cases in which the myocardial 
perfusion is no longer of importance (irreversible 
damage), the association of an IABP with the He- 
mopump device is not indicated. 
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